Malaria has become an urgent health problem in many countries including Indonesia, so that the reduction of malaria in Indonesia in 2030 becomes a benchmark in efforts to find alternative sources of malaria treatment derived from natural product, considering that several regions in Southeast Asia are currently reporting the occurrence of malaria drug resistance. Hyptis pectinata contains a hyptolide bioactive compound whose structure is similar to artemisinin, which is widely used as antimalarial. This plant is easily discovered in Indonesia, particularly in highland areas having sufficient sunlight. This study intends to formulate tablets from Hyptis pectinata extract as an antimalarial drug and to determine the acute toxicity effect caused by in-vivo administration of Hyptis pectinata extract and hyptolide. The study began with the formulation of Hyptis pectinata leaf extract by maceration using 96% ethanol solvent. The acute toxicity test employed male Sprague Dawley rats for 14 days as control with 5% CMC-Na, and doses for extract of 300, 500, 1000, 1500, and 2000 mg/kg., hyptolide of 20, 40, 80, 120, 160 mg/kg., and the manufacture of tablets through wet granulation method using gelatin binder at concentrations of 1%, 3%, and 5%. Parameters of acute oral toxicity test included toxic symptoms, body weight, mortality, and organ macroscopic examination. The granule tests carried out involved water content, flow time, and angle of repose, while the tablet quality test included weight uniformity, hardness, fragility, and disintegration time. The formulation results of Hyptis pectinata extract tablets with gelatin binders at concentrations of 1%, 3%, and 5% caused an influence on the physical properties of the granules' water content by 3.56%, 3.53%, and 3.49% respectively. The flow rate at 1%, 3%, and 5% gelatin was 5.64 seconds, 5.43 seconds, and 4.28 seconds. The repose at 1%, 3%, and 5% gelatin was 27.62°, 27 0.02°, and 24.38°. Further, the physical properties of tablets included weight uniformity at 1%, 3% and 5% gelatin was respectively 521.87 mg, 519.98 mg and 515.77 mg, hardness at 1%, 3% 5 % gelatin was 3.5 kg, 4.57 kg and 5.47 kg, friability at 1%, 3%, 5% gelatin was 0.04%, 0.031%, 0.026%, and disintegration time at 1%, 3%, 5 % gelatin was 19.89 minutes, 22.89 minutes and 72.33 minutes. The results of the acute toxicity test showed that administration of Hyptis pectinata extract at concentrations of 300, 500, 1000, 1500, and 2000 mg/kg and Hyptolide at concentrations of 20, 40, 80, 120, 160 mg/kg did not cause death in rats from all groups up to the 14th-day. It concluded that the manufacture of Hyptis pectinata tablets using a gelatin binder with varying concentrations of 1%, 3%, and 5% indicated that higher concentration of gelatin had an effect on increasing hardness, decreasing brittleness and longer disintegration time, and the best concentration of gelatin binder was at 3%. The results of the acute toxicity test of the Hyptis pectinata extracts and hyptolide did not show any toxic effects. [ABSTRACT FROM AUTHOR]